SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin

by Seufert J
Published 2015-11-01

Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

by Seufert J, Pegelow K, Bramlage P
Published 2013-11-01

Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insu...

by Pfohl M, Siegmund T, Pscherer S, Pegelow K, Seufert J
Published 2015-11-01